Page 1672 - Clinical Small Animal Internal Medicine
P. 1672
1610 Index
hepatobiliary disease (cont’d) HES see hydroxyethyl starches myopathies 813
VetBooks.ir normal hepatobiliary hiatal hernia 479, 479 pancreatitis 596–597, 604
HF see heart failure
pancreatic endocrine tumors 1299
neoplastic disease 667–668,
667–668
HIF‐1 see hypoxia inducible factor‐1
protozoal and arthropod‐borne
anatomy 659–660 high‐definition oscillometry infections 839–841
parenchymal disease 664–667, (HDO) 221–222 rabies 894
665–666 high‐dose dexamethasone suppression soft tissue sarcomas 1335
parenchymal structure 664 (HDDS) 53–54, 56 superficial necrolytic
radiography 659, 660–663, high‐fiber diet 589 dermatitis 1492
661–662 histamine‐2 receptor antagonists urinary tract tumors 1308
scintigraphy 659, 674 (H2RA) viral infections 843
ultrasonography 659, 663–674, esophageal disorders 560 histoplasmosis 990–992
663, 665–671, 673 exocrine pancreatic antifungal therapy 1050, 1052
vasculature 660, 664, 670–673, insufficiency 588–589 diagnosis 991–992, 991
671–673 gastritis and gastric ulceration 553 epidemiology and signalment 991
hepatobiliary tumors 1303–1306 motility disorders 575, 580 etiology/pathophysiology
bile duct tumors 1303–1304, 1306 histamine receptors 1362 990–991
diagnosis 1305 histiocytic sarcoma (HS) 1327, gastritis and gastric ulceration 550
epidemiology 1304 1443–1444 history and clinical signs 991
etiology/ histograms 11–12, 11 public health implications 992
pathophysiology 1303–1304 histology/histopathology treatment and prognosis 992
hepatocellular tumors 1303, acute kidney injury 1094 HLA see human leukocyte antigen
1305–1306 airway and lung cancers 1280 Ho:YAG laser lithotripsy
history and clinical signs alopecia 1438 1146–1147, 1146
1304–1305 approach to the dermatologic HO see hypertrophic osteopathy
mesenchymal tumors/ patient 1394–1396 HOAC see hypoadrenocorticism
sarcomas 1304, 1306 bacterial infections 844 HOD see hypertrophic
neuroendocrine tumors 1304, 1306 canine distemper virus 852 osteodystrophy
signalment 1304 canine histiocytic disorders Holter recording 213, 256
treatment and prognosis 1442–1448 homeopathy 1344
1305–1306 cardiac neoplasia 1273 hopping responses 733
hepatocellular adenoma 1303 central nervous system hormone receptors 30–31
hepatocellular carcinoma tumors 1248–1249 hormone replacement therapy
(HCC) 684–685 chronic enteropathies 636 (HRT) 1170
diagnosis 1305 cirrhosis 708–709 hormones and hormonal disorders
diagnostic imaging 667, 667 esophageal and stomach canine hypothyroidism 73
etiology/pathophysiology cancers 1284 cutaneous manifestations of systemic
1303–1304 exocrine pancreatic cancer 1293 disease 1481–1484
signalment 1304 exocrine pancreatic diabetes mellitus 93, 94
treatment and insufficiency 586 endocrinology 29–33, 30, 32
prognosis 1305–1306 feline acromegaly 45 neuroendocrinology 35–41, 37
hepatocutaneous syndrome feline coronavirus 875 principles of therapy of dermatologic
666, 666 forebrain disorders 775, 775 diseases 1402
hepatomegaly 95, 661, 662 fungal infections 845, 985–987, Horner syndrome 737, 827, 827
hepatotoxicity 1051 993, 993, 998, 1000, 1000 hospice care 1555–1564
hepatozoonosis 1011–1014 gastritis and gastric ulceration hospital‐acquired infections (HAI) see
diagnosis 1013–1014, 1013 552–553 nocosomial and multidrug‐
epidemiology 1012 hemangiosarcoma 1341 resistant infections
etiology/pathophysiology intestinal cancers 1288 hospital‐based cohort studies 20–21
1011–1012 liver disease 656–658 hospital‐based cross‐sectional
history and clinical signs 1013 lymphomas 1232, 1237 studies 17–18
signalment 1013 mammary cancer 1322 HPV see hepatic portal vein
treatment and prognosis 1014 mast cell tumors 1361–1362, 1365 HRIG see human anti‐rabies immune
herbal remedies 580 miscellaneous skin globulin
hereditary nephritis 1101 diseases 1496–1497 HRT see hormone replacement therapy
